China’s Innovative Drugs Go Global: From Followers to Game Changers

Frequent FIC/BIC deals, accelerated domestic regulation, and growing international attention—a clear trend is emerging: China’s innovative drugs are no longer followers but a significant variable in the global pharmaceutical value chain. However, “the true value of innovation now determines the...

By ALPHA

2025-08-26

+

China’s innovative drugs gain momentum in global expansion efforts

SHANGHAI, March 18 — In November 2023, fruquintinib, a new anti-tumor drug developed by Chinese pharmaceutical company HUTCHMED, was approved by the U.S. Food and Drug Administration (FDA) and prescribed in the United States within 48 hours following its approval....

By ALPHA

2025-07-23

+

Virtual mental health care visits: Making them work for youChinese-made new drugs big hit overseasVirtual mental health care visits: Making them work for you

Domestic pharma firms’ enthusiasm for going global driving business abroad With more Chinese-developed innovative drugs entering both US and European markets, China’s pharmaceutical sector is showing escalating prowess in innovation and global market penetration, said industry experts. “This (entering the...

By ALPHA

2025-07-23

+

Accelerating Chinese Innovative Drugs Going Global: International New Drug R&D Regulation Forum Successfully Held

A new round of technological revolution and industrial transformation in global biomedicine is accelerating, with innovative drugs becoming the most crucial strategic development direction in the biopharmaceutical industry. Since 2016, China’s innovative drug R&D has entered the fast track and...

By ALPHA

2025-07-23

+